Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1094 | 1019 | 1164 | 1098 | 1542 | 1597 |
Fund Return | 9.36% | 1.85% | 16.39% | 3.17% | 9.04% | 4.79% |
Place in category | 1612 | 1814 | 1417 | 816 | 639 | 393 |
% in Category | 73 | 82 | 67 | 46 | 41 | 40 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Income Fund D div USD hedged | 17.75B | 7.77 | 1.11 | 3.46 | ||
JPI Global Income Fund A acc USD he | 17.75B | 8.04 | 1.48 | 3.84 | ||
JPI Global Income Fund A div USD he | 17.75B | 8.06 | 1.50 | 3.85 | ||
JPI Global Income Fund A mth USD he | 17.75B | 8.03 | 1.47 | 3.83 | ||
JPI Global Income Fund C acc USD he | 17.75B | 8.52 | 2.16 | 4.52 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFSM European Value Fund A1 USD | 2.5B | 4.07 | -0.86 | 5.38 | ||
MFSM European Value Fund I1 USD | 2.5B | 8.16 | 0.07 | 7.02 | ||
MFSM European Value Fund N1 USD | 2.5B | 7.18 | -1.38 | 5.46 | ||
MFSM European Value Fund W1 USD | 2.5B | 8.08 | -0.15 | 6.78 | ||
Europe Equity Plus Fund A perf acc | 1.98B | 17.72 | 7.67 | 5.73 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 5.63 | 796.5 | -4.59% | |
ASML Holding | NL0010273215 | 5.42 | 757.30 | -0.33% | |
Louis Vuitton | FR0000121014 | 4.34 | 703.40 | +3.67% | |
AstraZeneca | GB0009895292 | 4.09 | 11,654.0 | -0.56% | |
Shell | GB00BP6MXD84 | 3.93 | 29.47 | +0.48% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review